218. Gidding HF. The impact of Australia’s measles control programme over the past decade. Epidemiology and Infection 2005;133:99-105. [Abstract]

219. Horby PW, Williams A, Burgess MA, Wang H. Prevalence and determinants of influenza vaccination in Australians aged 40 years and over – a national survey. Australian and New Zealand Journal of Public Health 2005;29:35-7. [Full text]

242. McIntyre P. Should dexamethasone be part of routine therapy of bacterial meningitis in industrialised countries? In: Pollard AJ, Finn A (eds). Hot topics in infection and immunity in children II. Series in: Advances in Experimental Medicine and Biology 2005;568:189-9. [Abstract]

244. Gidding HF, Brisson M, MacIntyre CR, Burgess MA. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Australian and New Zealand Journal of Public Health 2005;29:544-51. [Full text]

248. Lawrence G, Boyd I. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2005. Communicable Diseases Intelligence 2005;29:413-6. [Full text]